Peripheral blood transcriptome profiling enables monitoring disease progression in dystrophic mice and patients

Abstract excerpt

DMD is a rare disorder characterized by progressive muscle degeneration and premature death. Therapy development is delayed by difficulties to monitor efficacy non-invasively in clinical trials. In this study, we used RNA-sequencing to describe the pathophysiological changes in skeletal muscle of 3 dystrophic mouse models. We show how dystrophic changes in muscle are reflected in blood by analyzing paired muscle...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Adipose Tissue and Metabolism
• Share to Genetics, Aging, and Longevity in Model Organisms
• Share to Muscle Physiology and Disorders